Sprinklr Announces Fourth Quarter and Full Year Fiscal 2026 Results

Go back to Sprinklr Announces Fourth Quarter and Full Year Fiscal 2026 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 5.36 -0.19 (3.42%)
Previous Close $5.55    52 Week High $1.44 
Open $5.58    52 Week Low $0.06 
Day High $5.63    P/E N/A 
Day Low $5.35    EPS $-1.24 
Volume 1,500,563